Hera Biotech, a San Antonio-based startup developing a nonsurgical diagnostic test for endometriosis, won the Pitch Perfect contest at MedCity News’ INVEST Digital Health conference. The average diagnostic delay for the endometriosis is eight years, driven in large part by the fact that the only method currently used to diagnose the disease is a surgical procedure.
Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women's chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Organon’s proposed acquisition of Forendo Pharma is the company’s third since spinning out of Merck in the summer. Clinical-stage Forendo is developing a new, potentially more targeted approach to treating endometriosis.
The companies will test Biofourmis' sensor and artificial intelligence system in a clinical trial of more than 120 women with endometriosis.
Meditrina, which is based in Ann Arbor, Michigan, is using patents from AstraZeneca to treat women's health issues including endometriosis and uterine fibroids, which are abnormal growths or tumors that can cause pain and infertility. The company has completed Phase II trials on its two drugs - MPI-676 and MPI-674 - which treat endometriosis and abnormal uterine bleeding, respectively.